Wells Fargo & Company Emergent Bio Solutions Inc. Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

A detailed history of Wells Fargo & Company transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 3,535 shares of EBS stock, worth $31,001. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,535
Previous 22,306 84.15%
Holding current value
$31,001
Previous $56,000 57.14%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$1.86 - $6.98 $34,914 - $131,021
-18,771 Reduced 84.15%
3,535 $24,000
Q1 2024

May 10, 2024
BUY
$1.5 - $3.41 $3,759 - $8,545
2,506 Added 12.66%
22,306 $56,000
Q4 2023

Feb 09, 2024
BUY
$1.82 - $3.16 $4,422 - $7,678
2,430 Added 13.99%
19,800 $47,000
Q3 2023

Nov 13, 2023
SELL
$3.17 - $7.91 $349,540 - $872,196
-110,265 Reduced 86.39%
17,370 $59,000
Q2 2023

Aug 15, 2023
BUY
$7.35 - $13.21 $273,868 - $492,217
37,261 Added 41.23%
127,635 $938,000
Q1 2023

May 12, 2023
BUY
$7.79 - $16.29 $556,478 - $1.16 Million
71,435 Added 377.18%
90,374 $936,000
Q4 2022

Feb 13, 2023
BUY
$11.0 - $21.45 $90,772 - $177,005
8,252 Added 77.22%
18,939 $223,000
Q3 2022

Nov 14, 2022
SELL
$20.09 - $35.8 $3.31 Million - $5.9 Million
-164,923 Reduced 93.91%
10,687 $224,000
Q2 2022

Aug 12, 2022
SELL
$27.42 - $43.63 $3.11 Million - $4.95 Million
-113,540 Reduced 39.27%
175,610 $5.45 Million
Q1 2022

May 16, 2022
SELL
$36.48 - $52.22 $973,359 - $1.39 Million
-26,682 Reduced 8.45%
289,150 $11.9 Million
Q4 2021

Feb 14, 2022
SELL
$33.11 - $55.01 $3.35 Million - $5.57 Million
-101,319 Reduced 24.29%
315,832 $13.7 Million
Q3 2021

Nov 15, 2021
BUY
$50.07 - $66.05 $6.31 Million - $8.33 Million
126,093 Added 43.32%
417,151 $20.9 Million
Q2 2021

Aug 16, 2021
SELL
$56.61 - $80.46 $9.65 Million - $13.7 Million
-170,494 Reduced 36.94%
291,058 $18.3 Million
Q1 2021

May 13, 2021
BUY
$86.23 - $125.19 $1.57 Million - $2.29 Million
18,255 Added 4.12%
461,552 $42.9 Million
Q4 2020

Feb 09, 2021
SELL
$79.17 - $111.47 $13 Million - $18.3 Million
-164,414 Reduced 27.05%
443,297 $39.7 Million
Q3 2020

Nov 05, 2020
BUY
$81.91 - $134.94 $11.5 Million - $19 Million
140,558 Added 30.09%
607,711 $62.8 Million
Q2 2020

Aug 13, 2020
SELL
$54.33 - $89.52 $112,680 - $185,664
-2,074 Reduced 0.44%
467,153 $36.9 Million
Q1 2020

May 14, 2020
BUY
$49.34 - $68.76 $23.2 Million - $32.3 Million
469,227 New
469,227 $27.2 Million

Others Institutions Holding EBS

# of Institutions
147
Shares Held
30.4M
Call Options Held
137K
Put Options Held
706K
View Full List

About Emergent BioSolutions Inc.

EBS Quotes by TradingView
  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $437M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email